ScinoPharm Taiwan, Ltd. (TPE:1789)
18.00
-0.75 (-4.00%)
Nov 19, 2026, 1:30 PM CST
ScinoPharm Taiwan Market Cap
ScinoPharm Taiwan has a market cap or net worth of 14.23 billion as of November 19, 2026. It is the 14,959th most valuable company in the world and the 477th biggest in Taiwan. Its market cap has increased by 5.88% in one year.
Market Cap
14.23B
Enterprise Value
12.01B
Revenue
3.04B
Global Rank
Country Rank
#477 Taiwan
PE Ratio
1,011.63
ChartMarket Cap Chart
Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 14.23B, a decrease of -53.23%. That is a compound annual growth rate of -4.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 14.23B | 7.46% |
| Dec 31, 2025 | 13.24B | -24.04% |
| Dec 31, 2024 | 17.44B | -16.48% |
| Dec 29, 2023 | 20.88B | 3.73% |
| Dec 30, 2022 | 20.12B | 3.25% |
| Dec 30, 2021 | 19.49B | -14.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 45.12B |
| Lotus Pharmaceutical | 33.98B |
| Center Laboratories | 22.07B |
| TTY Biopharm Company | 20.59B |
| Handa Pharmaceuticals | 17.15B |
| YungShin Global Holding | 15.77B |
| Synmosa Biopharma | 14.42B |
| Foresee Pharmaceuticals | 11.03B |